四川医学
四川醫學
사천의학
SICHUAN MEDICAL JOURNAL
2009年
7期
1026-1027
,共2页
原发性肾病综合征%血栓通%灯盏细辛%抗凝%降血脂
原髮性腎病綜閤徵%血栓通%燈盞細辛%抗凝%降血脂
원발성신병종합정%혈전통%등잔세신%항응%강혈지
nephrotie syndrome%xueshuantong%erigeron%anticoagulation%lipid-lowering
目的 观察血栓通和灯盏细辛在原发性肾病综合征的治疗作用和不良反应,并进行疗效的比较.方法 对56例原发性肾病综合患者,随机分为血栓通组和灯盏细辛组,分别在给予常规治疗的基础上加用血栓通和灯盏细辛治疗4周.结果 两组均具有不同程度的降血脂和减轻血液高凝状态的作用,并协助减少尿蛋白,提高血浆清蛋白(P<0.05),且无明显不良反应.结论 血栓通和灯盏细辛在原发性肾病综合征中疗效确切,不良反应极少,使用安全、方便,值得临床推广应用.
目的 觀察血栓通和燈盞細辛在原髮性腎病綜閤徵的治療作用和不良反應,併進行療效的比較.方法 對56例原髮性腎病綜閤患者,隨機分為血栓通組和燈盞細辛組,分彆在給予常規治療的基礎上加用血栓通和燈盞細辛治療4週.結果 兩組均具有不同程度的降血脂和減輕血液高凝狀態的作用,併協助減少尿蛋白,提高血漿清蛋白(P<0.05),且無明顯不良反應.結論 血栓通和燈盞細辛在原髮性腎病綜閤徵中療效確切,不良反應極少,使用安全、方便,值得臨床推廣應用.
목적 관찰혈전통화등잔세신재원발성신병종합정적치료작용화불량반응,병진행료효적비교.방법 대56례원발성신병종합환자,수궤분위혈전통조화등잔세신조,분별재급여상규치료적기출상가용혈전통화등잔세신치료4주.결과 량조균구유불동정도적강혈지화감경혈액고응상태적작용,병협조감소뇨단백,제고혈장청단백(P<0.05),차무명현불량반응.결론 혈전통화등잔세신재원발성신병종합정중료효학절,불량반응겁소,사용안전、방편,치득림상추엄응용.
Objective To investigate the effect of xueshuantong and erigeron injection on antieoagulative therapy in ne-phrotic syndrome. Methods 56 patients with primary nephrotic syndrome were randomized into xueshuantong group and erigeron group, who were given xueshuantong and erigeron injection for 4 weeks on top of the regular therapy, respectively. Results Lipid-lowering and anticoagulative effects were observed in the 2 groups after the therapy. Both xueshuantong and erigeron injection re-duced proteinufia and improved hypoalbuminemia(P<0.05) without major adverse events. Conclusion Both xueshuantong and erigeron injection are suggested to be safe and effective for anticoagulation in primary nephrotic syndrome.
